BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20363574)

  • 1. Technical aspects of MR perfusion.
    Sourbron S
    Eur J Radiol; 2010 Dec; 76(3):304-13. PubMed ID: 20363574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion and perfusion of the kidney.
    Notohamiprodjo M; Reiser MF; Sourbron SP
    Eur J Radiol; 2010 Dec; 76(3):337-47. PubMed ID: 20580179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
    Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
    Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion and perfusion imaging of bone marrow.
    Biffar A; Dietrich O; Sourbron S; Duerr HR; Reiser MF; Baur-Melnyk A
    Eur J Radiol; 2010 Dec; 76(3):323-8. PubMed ID: 20381277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced breast MR imaging.
    Moon M; Cornfeld D; Weinreb J
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting.
    Radjenovic A; Ridgway JP; Smith MA
    Phys Med Biol; 2006 May; 51(9):N187-97. PubMed ID: 16625029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors.
    Bergamino M; Bonzano L; Levrero F; Mancardi GL; Roccatagliata L
    Phys Med; 2014 Sep; 30(6):635-43. PubMed ID: 24793824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
    Choyke PL; Dwyer AJ; Knopp MV
    J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of early response to radiotherapy of uterine carcinoma with dynamic contrast-enhanced MR imaging using pixel analysis of MR perfusion imaging.
    Takayama Y; Ohno T; Kishimoto R; Kato S; Yoneyama R; Kandatsu S; Tsujii H; Obata T
    Magn Reson Imaging; 2009 Apr; 27(3):370-6. PubMed ID: 18768283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundamentals of quantitative dynamic contrast-enhanced MR imaging.
    Paldino MJ; Barboriak DP
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):277-89. PubMed ID: 19406359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of perfusion measurement in brain tumours at 3 Tesla MR: Arterial spin labeling versus dynamic susceptibility contrast-enhanced MRI.
    Lehmann P; Monet P; de Marco G; Saliou G; Perrin M; Stoquart-Elsankari S; Bruniau A; Vallée JN
    Eur Neurol; 2010; 64(1):21-6. PubMed ID: 20558984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue.
    Weber MA; Günther M; Lichy MP; Delorme S; Bongers A; Thilmann C; Essig M; Zuna I; Schad LR; Debus J; Schlemmer HP
    Invest Radiol; 2003 Nov; 38(11):712-8. PubMed ID: 14566181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion measurement using DCE-MRI: implications for hyperthermia.
    Lüdemann L; Wust P; Gellermann J
    Int J Hyperthermia; 2008 Feb; 24(1):91-6. PubMed ID: 18214772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenomenological universalities: a novel tool for the analysis of dynamic contrast enhancement in magnetic resonance imaging.
    Gliozzi AS; Mazzetti S; Delsanto PP; Regge D; Stasi M
    Phys Med Biol; 2011 Feb; 56(3):573-86. PubMed ID: 21212471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MR imaging of the liver: current status and future directions.
    Do RK; Rusinek H; Taouli B
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):339-49. PubMed ID: 19406362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
    Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
    Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
    Rosen MA; Schnall MD
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.